In addition, M1 macrophages, which are considered antineoplastic, became more numerous in the BTZ-treated shB-Myb colorectal cancer cells–bearing mice, as evidenced by the increased CD11b/iNOS and CD11b/GBP5 double-positive cells, which was quantified (Fig. 7B–E). Here, NOS2 is linked to colorectal cancer.